Tag #Hrt

Showing 1 to 6 of 6 results

theguardian.com

🌐 85% Global Worthiness

Sep 7, 10:17

Over-the-Counter Menopause Hormone Tests Deemed Clinically Useless

Senior doctors warn that readily available, expensive hormone tests for menopause are misleading, medically unnecessary, and risk undermining women's healthcare, urging reliance on symptom-based diagnosis instead.

Over-the-Counter Menopause Hormone Tests Deemed Clinically Useless

Senior doctors warn that readily available, expensive hormone tests for menopause are misleading, medically unnecessary, and risk undermining women's healthcare, urging reliance on symptom-based diagnosis instead.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How are these tests impacting women's healthcare and expectations?

The tests create unrealistic expectations about hormone replacement therapy (HRT), particularly regarding mental health issues and a 'quick fix'. This leads to increased demand for unregulated treatments like expensive bioidentical hormones, and undermines trust in medical professionals.

npr.org

🌐 85% Global Worthiness

Jul 25, 13:13

FDA Panel Urges Removal of Black Box Warnings for Low-Dose Vaginal Estrogen

An FDA panel recently recommended removing black box warnings from low-dose vaginal estrogen treatments due to concerns that they overstate risks and deter women from using beneficial menopause medications; this decision follows decades of evolving understanding of HRT safety and efficacy.

FDA Panel Urges Removal of Black Box Warnings for Low-Dose Vaginal Estrogen

An FDA panel recently recommended removing black box warnings from low-dose vaginal estrogen treatments due to concerns that they overstate risks and deter women from using beneficial menopause medications; this decision follows decades of evolving understanding of HRT safety and efficacy.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How have evolving scientific understandings of HRT risks influenced current calls for changes to FDA labeling?

The debate around hormone replacement therapy (HRT) safety has shifted significantly. Initially, concerns over increased cancer risks led to widespread reluctance to prescribe HRT. However, recent research suggests these risks were overstated for certain low-dose treatments, prompting calls to revise FDA labeling. This highlights the evolution of medical understanding and its impact on patient care.

dailymail.co.uk

🌐 75% Global Worthiness

Jul 3, 16:14

Delayed POI Diagnosis Underscores Need for Improved Medical Care and Education

Corinna Bordolli, 29, was diagnosed with premature ovarian insufficiency (POI) at 15, experiencing various symptoms until receiving appropriate hormone replacement therapy (HRT) after self-diagnosing. Her case highlights delayed diagnosis challenges and the need for better medical education and trea...

Delayed POI Diagnosis Underscores Need for Improved Medical Care and Education

Corinna Bordolli, 29, was diagnosed with premature ovarian insufficiency (POI) at 15, experiencing various symptoms until receiving appropriate hormone replacement therapy (HRT) after self-diagnosing. Her case highlights delayed diagnosis challenges and the need for better medical education and trea...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do societal expectations surrounding femininity and fertility affect women diagnosed with POI, and what coping mechanisms are available?

POI often goes undiagnosed, leading to long-term health risks like weakened bones and cognitive decline. Corinna's experience highlights the need for better education and earlier diagnosis of POI, particularly among younger women. Untreated POI significantly impacts quality of life, affecting physical health, emotional well-being, and fertility.

forbes.com

🌐 90% Global Worthiness

Jul 25, 07:14

The M Factor Film's Global Impact on Menopause Awareness and Care

The M Factor film, a short documentary on menopause, has been screened globally, significantly impacting public understanding, clinical care, and policy, resulting in increased doctor consultations and improved clinician knowledge.

The M Factor Film's Global Impact on Menopause Awareness and Care

The M Factor film, a short documentary on menopause, has been screened globally, significantly impacting public understanding, clinical care, and policy, resulting in increased doctor consultations and improved clinician knowledge.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the global impact of The M Factor film on menopause awareness and healthcare practices?

The M Factor film, launched in late 2024, has significantly impacted global conversations and understanding of menopause. Screened in 50 US states, over 50 countries, and at the World Economic Forum, the film resulted in 80% of viewers better understanding menopause and 75% being more likely to consult a doctor.

it.euronews.com

🌐 75% Global Worthiness

Jul 23, 10:16

France to Revise Hormone Replacement Therapy Guidelines in 2026

Hormone Replacement Therapy (HRT), used to treat menopausal symptoms, faced controversy after a 2002 US study linked it to increased health risks; however, this study's methodology is now debated, and France is revising its HRT guidelines in 2026 to reflect updated research and address past misconce...

France to Revise Hormone Replacement Therapy Guidelines in 2026

Hormone Replacement Therapy (HRT), used to treat menopausal symptoms, faced controversy after a 2002 US study linked it to increased health risks; however, this study's methodology is now debated, and France is revising its HRT guidelines in 2026 to reflect updated research and address past misconce...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential future implications of France's upcoming HRT guideline revision in 2026 for women's health and medical practice?

France's Haute Autorité de Santé (HAS) will revise HRT guidelines in 2026, reflecting updated evidence and addressing past misinterpretations. This reassessment underscores a shift toward personalized medicine, aiming to empower women with informed choices based on current data and dispel outdated fears surrounding HRT. The 2026 update could mark a turning point for HRT, restoring its place as a viable option.

dailymail.co.uk

🌐 85% Global Worthiness

Jun 2, 19:17

Mounjaro and Oral HRT: Increased Womb Cancer Risk

The British Menopause Society warns that women taking oral hormone replacement therapy (HRT) should consult their doctors before using the weight-loss jab Mounjaro, due to concerns about increased womb cancer risk because Mounjaro may reduce the absorption of oral progestogen, a component of HRT, po...

Mounjaro and Oral HRT: Increased Womb Cancer Risk

The British Menopause Society warns that women taking oral hormone replacement therapy (HRT) should consult their doctors before using the weight-loss jab Mounjaro, due to concerns about increased womb cancer risk because Mounjaro may reduce the absorption of oral progestogen, a component of HRT, po...

Progress

60% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate risks for women taking oral HRT who also start using Mounjaro for weight loss?

The British Menopause Society (BMS) advises women on oral hormone replacement therapy (HRT) to consult their doctors before using the weight-loss drug Mounjaro due to potential increased womb cancer risk. Mounjaro may reduce the absorption of oral progestogen in HRT, potentially leading to womb lining thickening. This risk is heightened for obese and diabetic women already at higher risk.

Showing 1 to 6 of 6 results